Insider Trading & Ownership - Eisele Jeffrey

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Eisele Jeffrey
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-01-29
Sale
2024-01-31
4:23 pm
Apellis Pharmaceuticals Inc.APLSEisele Jeffrey
Chief Development Officer
1,250$65.22$81,52457,208
(Direct)
View
2024-01-23
Sale
2024-01-24
4:03 pm
Apellis Pharmaceuticals Inc.APLSEisele Jeffrey
Chief Development Officer
7,378$63.69$469,90558,458
(Direct)
View
2024-01-22
Sale
2024-01-23
6:05 pm
Apellis Pharmaceuticals Inc.APLSEisele Jeffrey
Chief Development Officer
1,607$65$104,44965,836
(Direct)
View
2024-01-17
Sale
2024-01-18
4:55 pm
Apellis Pharmaceuticals Inc.APLSEisele Jeffrey
Chief Development Officer
5,207$65.58$341,47567,443
(Direct)
View
2024-01-16
Sale
2024-01-17
12:24 pm
Apellis Pharmaceuticals Inc.APLSEisele Jeffrey
Chief Development Officer
438$66.81$29,262101,017
(Direct)
View
2023-12-26
Sale
2023-12-28
4:13 pm
Apellis Pharmaceuticals Inc.APLSEisele Jeffrey
Chief Development Officer
303$59.7$18,08953,580
(Direct)
View
2023-02-23
Sale
2023-02-27
4:34 pm
Apellis Pharmaceuticals Inc.APLSEisele Jeffrey
Chief Development Officer
1,646$68.76$113,17953,883
(Direct)
View
2023-01-30
Sale
2023-01-31
4:51 pm
Apellis Pharmaceuticals Inc.APLSEisele Jeffrey
Chief Development Officer
883$52.76$46,58746,468
(Direct)
View
2023-01-23
Sale
2023-01-25
4:14 pm
Apellis Pharmaceuticals Inc.APLSEisele Jeffrey
Chief Development Officer
4,479$51.58$231,02747,718
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-01-16
Option Award
2024-01-17
12:24 pm
N/A
N/A
Apellis Pharmaceuticals Inc.APLSEisele Jeffrey
Chief Development Officer
19,508$0101,017
(Direct)
View
2024-01-16
Option Award
2024-01-17
12:24 pm
N/A
2034-01-15
Apellis Pharmaceuticals Inc.APLSEisele Jeffrey
Chief Development Officer
28,367$66.3101,017
(Direct)
View
2023-02-21
Option Award
2023-02-22
06:46 am
N/A
2032-01-20
Apellis Pharmaceuticals Inc.APLSEisele Jeffrey
Chief Development Officer
23,909$069,552
(Direct)
View
2023-02-21
Tax Withholding
2023-02-22
06:46 am
N/A
N/A
Apellis Pharmaceuticals Inc.APLSEisele Jeffrey
Chief Development Officer
825$58.569,552
(Direct)
View
2023-01-27
Tax Withholding
2023-01-30
4:58 pm
N/A
N/A
Apellis Pharmaceuticals Inc.APLSEisele Jeffrey
Chief Development Officer
367$52.7747,351
(Direct)
View
2023-01-20
Tax Withholding
2023-01-24
5:15 pm
N/A
N/A
Apellis Pharmaceuticals Inc.APLSEisele Jeffrey
Chief Development Officer
2,033$52.0552,197
(Direct)
View
2023-01-12
Option Award
2023-01-17
7:35 pm
N/A
N/A
Apellis Pharmaceuticals Inc.APLSEisele Jeffrey
Chief Development Officer
22,580$089,702
(Direct)
View
2023-01-12
Option Award
2023-01-17
7:35 pm
N/A
2033-01-11
Apellis Pharmaceuticals Inc.APLSEisele Jeffrey
Chief Development Officer
35,472$52.6689,702
(Direct)
View
2022-04-25
Other
2022-12-23
4:15 pm
N/A
N/A
Apellis Pharmaceuticals Inc.APLSEisele Jeffrey
Exec VP, Program Team Lead
1,250$032,900
(Direct)
View
2022-12-22
Tax Withholding
2022-12-23
4:15 pm
N/A
N/A
Apellis Pharmaceuticals Inc.APLSEisele Jeffrey
Exec VP, Program Team Lead
89$51.6832,900
(Direct)
View
2022-01-28
Tax Withholding
2022-02-01
6:09 pm
N/A
N/A
Apellis Pharmaceuticals Inc.APLSEisele Jeffrey
Exec VP, Program Team Lead
434$38.5932,989
(Direct)
View
2022-01-21
Option Award
2022-01-25
4:50 pm
N/A
2032-01-20
Apellis Pharmaceuticals Inc.APLSEisele Jeffrey
Exec VP, Program Team Lead
63,002$070,374
(Direct)
View
2021-12-22
Tax Withholding
2021-12-23
4:49 pm
N/A
N/A
Apellis Pharmaceuticals Inc.APLSEisele Jeffrey
Exec VP, Program Team Lead
89$47.827,372
(Direct)
View
2021-03-01
Option Award
2021-03-03
4:07 pm
N/A
2031-02-28
Apellis Pharmaceuticals Inc.APLSEisele Jeffrey
Exec VP, Program Team Lead
8,750$014,961
(Direct)
View
2021-01-28
Option Award
2021-02-01
4:36 pm
N/A
2031-01-27
Apellis Pharmaceuticals Inc.APLSEisele Jeffrey
Exec VP, Program Team Lead
35,000$036,211
(Direct)
View
2020-12-23
Option Award
2020-12-23
5:41 pm
N/A
N/A
Apellis Pharmaceuticals Inc.APLSEisele Jeffrey
Exec VP, Program Team Lead
1,211$01,211
(Direct)
View

Ownership
2020-10-06
4:37 pm
N/A
2030-08-31
Apellis Pharmaceuticals Inc.APLSEisele Jeffrey
See Remarks
0$0125,000
(Direct)
View